NASDAQ : BTMD
biote Corp. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 1.11 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 37.63M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 38.31M |
| Enterprise Value | 155.78M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 28.68M |
| Shares Outstanding | 33.90M |
| Shares Change (YoY) | -7.45% |
| Shares Change (QoQ) | -20.47% |
| Owned by Insiders (%) | 19.43% |
| Owned by Institutions (%) | 39.12% |
| Float | 16.46M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 6.23 |
| Forward PE | 38.67 |
| PS Ratio | 0.21 |
| Forward PS | 0.21 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1.89 |
| P/OCF Ratio | 1.54 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 26.49 |
| EV / Sales | 0.85 |
| EV / EBITDA | 6.09 |
| EV / EBIT | 6.85 |
| EV / FCF | 7.80 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.43 |
| Quick Ratio | 0.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.88 |
| Debt / FCF | 6.47 |
| Interest Coverage | 2.42 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 13.70% |
| Return on Invested Capital (ROIC) | 23.60% |
| Return on Capital Employed (ROCE) | 31.62% |
| Weighted Average Cost of Capital (WACC) | 6.95% |
| Revenue Per Employee | $823,009 |
| Profits Per Employee | $26,260 |
| Employee Count | 223 |
| Asset Turnover | 1.78 |
| Inventory Turnover | 3.22 |
Taxes
| Measure | Value |
|---|
| Income Tax | 3.18M |
| Effective Tax Rate | 30.98% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.69 |
| 52-Week Price Change | -59.76% |
| 50-Day Moving Average | 1.29 |
| 200-Day Moving Average | 1.82 |
| Relative Strength Index (RSI) | 48.16 |
| Average Volume (20 Days) | 105,701 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.18M |
| Short Previous Month | 1.08M |
| Short % of Shares Out | 3.48% |
| Short % of Float | 7.17% |
| Short Ratio (days to cover) | 8.62 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 183.53M |
| Gross Profit | 127.46M |
| Operating Income | 22.64M |
| Pretax Income | 10.26M |
| Net Income | 5.86M |
| EBITDA | 25.48M |
| EBIT | 22.64M |
| Earnings Per Share (EPS) | $0.18 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 11.17M |
| Total Debt | 128.64M |
| Net Cash | -117.47M |
| Net Cash Per Share | -$3.47 |
| Equity (Book Value) | -58.19M |
| Book Value Per Share | -2.38 |
| Working Capital | 12.94M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 24.37M |
| Capital Expenditures | -4.50M |
| Depreciation & Amortization | 2.85M |
| Net Borrowing | 89.31M |
| Free Cash Flow | 19.87M |
| FCF Per Share | $0.59 |
Margins
| Measure | Value |
|---|
| Gross Margin | 69.45% |
| Operating Margin | 12.33% |
| Pretax Margin | 5.59% |
| Profit Margin | 3.19% |
| EBITDA Margin | 13.89% |
| EBIT Margin | 12.33% |
| FCF Margin | 10.83% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 7.45% |
| Shareholder Yield | 7.45% |
| Earnings Yield | 16.05% |
| FCF Yield | 52.81% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $2.61 |
| Price Target Difference | 131.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 0.82% |
| EPS Growth Forecast (3Y) | -3.83% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.3 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |